Submucosal Tunnel Endoscopic Resection for Extraluminal Tumors: a Novel Endoscopic Method for En Bloc Resection of Predominant Extraluminal Growing Subepithelial Tumors or Extra-Gastrointestinal Tumors (with Videos)

Ming-Yan Cai,Bo-Qun Zhu,Mei-Dong Xu,Wen-Zheng Qin,Yi-Qun Zhang,Wei-Feng Chen,Marie Ooi,Quan-Lin Li,Li-Qing Yao,Ping-Hong Zhou
DOI: https://doi.org/10.1016/j.gie.2018.02.032
IF: 10.396
2018-01-01
Gastrointestinal Endoscopy
Abstract:Background and Aims: The management of subepithelial tumors with a predominant extraluminal growth pattern or extra-GI tumors can be challenging and traditionally requires a surgical resection that is not only invasive but may carry a significant risk of morbidity and mortality. We aimed to assess the feasibility, safety, and efficacy of a novel endoscopic technique termed submucosal tunnel endoscopic resection for extraluminal tumors (STER-ET). Methods: We prospectively enrolled patients who underwent STER-ET for GI subepithelial tumors with a predominant extraluminal growth pattern or extra-GI tumors located at the level of cardia or the proximal part of the lesser curvature of the stomach seen on cross-sectional imaging between January 2016 and March 2017. Results: Eight patients underwent STER-ET. The mean (+/- standard deviation) tumor size was 2.8 +/- 0.6 cm and 2.3 +/- 0.8 cm in longest and shortest dimension, respectively. The average procedure time was 67 +/- 4.4 minutes. The rates of curative en bloc resection and en bloc retrieval was 100% and 87.5%, respectively. On final histology, 6 tumors were GI stromal tumors, 1 was a schwannoma, and 1 was a foregut cyst. Five patients had capnoperitoneum during the procedure and required abdominal decompression. One patient had a small mucosotomy successfully treated with a hemostatic clip. There were no major adverse events or deaths. The median length of hospital stay was 3 days. There was no residual tumor on surveillance imaging after a mean follow-up period of 10.0 +/- 2.1 months. Conclusions: STER-ET is a novel technique that appears to be safe and effective in achieving a curative resection for GI subepithelial tumors with a predominantly extraluminal growth pattern or extraluminal tumors in a selected group of patients. However, larger studies are required to validate our finding.
What problem does this paper attempt to address?